SCHEMBL7701876

SCHEMBL7701876

CSc1nc(O)c(-c2ccc(Cl)cc2)c(O)n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 3/20 0.43
NPC1 O15118 2/20 0.43
KMT2A Q03164 5/20 0.42
KDM4E B2RXH2 4/20 0.42
MEN1 O00255 3/20 0.42
LMNA P02545 2/20 0.42
MAPK1 P28482 2/20 0.42
MAPT P10636 2/20 0.42
ALOX15 P16050 1/20 0.42
HTT P42858 1/20 0.42
HSD17B10 Q99714 1/20 0.42
CTDSP1 Q9GZU7 1/20 0.41
HSP90AA1 P07900 1/20 0.41
L3MBTL1 Q9Y468 3/20 0.40
TDP1 Q9NUW8 2/20 0.40
POLB P06746 2/20 0.40
SMN1; SMN2 Q16637 3/20 0.39
CYP1A2 P05177 2/20 0.39
CYP2C9 P11712 2/20 0.39
SLC22A1 O15245 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7818543 0.83 CYP1A2 (0.46) RAB9ANPC1KMT2AMEN1LMNA
SCHEMBL4810291 0.81 KDM4E (0.42) KMT2AKDM4EMEN1MAPTSMN1; SMN2
SCHEMBL7699598 0.81 KDM4E (0.49) RAB9ANPC1KMT2AKDM4EMEN1
SCHEMBL13903600 0.81 HSP90AA1 (0.49) RAB9ANPC1KMT2AKDM4EMEN1
SCHEMBL11184601 0.75 NPSR1 (0.47) RAB9ANPC1KMT2AKDM4EMEN1
SCHEMBL7695788 0.75 KDM4E (0.38) RAB9ANPC1KMT2AKDM4EMEN1
SCHEMBL7699109 0.74 CYP1A2 (0.50) RAB9ANPC1KMT2AKDM4EMEN1
SCHEMBL4802465 0.74 CNR1 (0.39) KMT2AKDM4EMEN1MAPTTDP1
SCHEMBL5179315 0.73 POLB (0.42) RAB9AKDM4EMAPK1POLBCYP2C9
SCHEMBL7699107 0.72 IKBKB (0.43) RAB9ANPC1KMT2AKDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2002083650-A1 NOVEL SULFONYLAMINO-PYRIMIDINES ACTELION PHARMACEUTICALS LTD (CH) 2002-10-24 WO disclosed